vancomycin has been researched along with arbekacin in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 27 (39.71) | 18.2507 |
2000's | 29 (42.65) | 29.6817 |
2010's | 11 (16.18) | 24.3611 |
2020's | 1 (1.47) | 2.80 |
Authors | Studies |
---|---|
Inagaki, H; Kawakami, K; Kawato, HC; Matsuhashi, N; Miyauchi, RN; Miyauchi, S; Ohki, H; Takahashi, H; Takemura, M | 1 |
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
Inagaki, H; Ito, M; Kawakami, K; Matsuhashi, N; Miyauchi, R; Ohki, H; Takahashi, H; Takemura, M | 1 |
Majik, MS; Rodrigues, L; Tilve, SG | 1 |
Watanabe, A | 1 |
Arakawa, M; kawashima, T; Tsukasa, H; Wada, K | 1 |
Nitta, Y; Sunakawa, K; Yokota, T | 1 |
Inamatsu, T | 1 |
Kobayashi, Y | 1 |
Hayashi, I; Ichiki, M; Ishikawa, T; Karato, A; Niida, M; Ogawa, M; Sakurai, M; Sekine, I; Shiotani, J; Yoshida, T | 1 |
Nishioka, K; Tanno, Y; Wang, R | 1 |
Hashimoto, H | 1 |
Aoki, Y | 1 |
Ishii, T; Orikasa, Y; Takase, Y; Takayama, Y | 1 |
Goto, S; Sugano, T; Takada, T; Takase, Y; Tsuji, A; Yamaguchi, K; Yoshida, T | 1 |
Asaoka, H; Niizato, T; Nishiyama, S; Ohnishi, M; Saito, A | 1 |
Ichiyama, S; Shimokata, K | 1 |
Arakawa, M; Honma, T; Hoshino, S; Miyao, H; Sato, S; Sega, H; Shimazu, Y; Tsukada, H; Wada, K; Yoshikawa, H | 1 |
Fujita, K; Kato, H; Nagamachi, Y; Okubo, T; Suzuki, T | 1 |
Tsuji, A | 1 |
Natori, H; Oizumi, K; Tanaka, K; Tokunaga, N | 1 |
Fuse, H; Katayama, T; Kazama, T; Muraishi, Y; Okumura, A; Sakamoto, M; Tsuritani, S | 1 |
Deguchi, T; Ito, Y; Kanematsu, M; Kawada, Y; Komeda, H; Okano, M; Saitoh, A; Takahashi, Y; Tokuyama, H; Yamada, S | 1 |
Kubota, T; Matsui, K; Ohashi, K; Watanabe, T | 1 |
Hanaki, H; Hiramatsu, K; Ino, T; Oguri, T; Tenover, FC; Yabuta, K | 1 |
Higurashi, Y; Nakahara, K; Okuzumi, K; Yoneyama, A | 1 |
Koizumi, A; Konishi, M; Maeda, K; Masutani, T; Mikasa, K; Mori, K; Narita, N; Sano, R; Sawaki, M; Tsujimoto, M | 1 |
Hiramatsu, K; Inaba, Y | 1 |
Fukayama, M | 1 |
Hashimoto, Y; Inui, K; Kokuryo, T; Nakamura, T; Okuda, M | 1 |
Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I | 2 |
Arakawa, K; Kono, K; Takeda, S; Yasunaka, K | 1 |
Chow, JW; Kariyama, R; Kumon, H; You, I; Zervos, MJ | 1 |
Aihara, Y; Fukamachi, K; Hori, T; Imamura, T; Kasuya, H; Kawashima, A; Kikuchi, K; Ochiai, T; Shiseki, M; Tozuka, K; Yamaguchi, K | 1 |
Akins, RL; Rybak, MJ | 1 |
Ishikawa, S; Koyano, T; Morishita, Y; Noda, D; Ooki, S; Shimizu, H; Takahashi, T | 1 |
Chow, JW; Kak, V; Kariyama, R; Kumon, H; You, I; Zervos, MJ | 1 |
Araake, M; Hara, T; Miyata, A; Ogawa, H; Tani, M | 1 |
Araake, M; Hanaki, H; Hiramatsu, K; Miyata, A; Ogawa, H | 1 |
Hanaki, H | 1 |
Fujita, A; Inagaki, K; Inatomi, T; Kinoshita, S; Koizumi, N; Sano, Y; Sotozono, C | 1 |
Hijioka, S; Nakata, R; Nishimura, T; Sugita, K; Yoshinami, Y | 1 |
Choi, JH; Choi, SM; Chun, HS; Kang, MW; Lee, DG; Shin, WS; Yim, DS; Yoo, JH | 1 |
Kimura, T; Kubo, H; Matsuura, N; Shimada, S; Sunakawa, K; Yago, K | 1 |
Shiotani, J; Takehana, K | 1 |
LaPlante, KL; Rybak, MJ | 1 |
Hayashi, H; Matsumoto, Y; Matsuzaki, T; Saito, A; Shimizu, M | 1 |
Heo, ST; Ki, HK; Kiem, S; Ko, KS; Lee, JY; Moon, CS; Oh, WS; Peck, KR; Song, JH | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
Sunakawa, K | 1 |
Kimura, T; Kokubun, H; Yago, K | 1 |
Aoyama, T; Hayashi, H; Matsumoto, Y; Matsuzaki, T; Saito, A | 1 |
Ariyoshi, N; Hasegawa, A; Hashimoto, N; Igari, H; Kitada, M; Nakamura, H; Nakamura, Y; Nakasa, H; Nakazawa, K; Nomura, F; Sato, T; Watanabe, A; Watanabe, M; Yokoyama, I | 1 |
Aoyama, T; Hayashi, H; Iwahori, T; Kawai, M; Matsumoto, Y; Matsuzaki, T; Mizuno, Y; Saito, A | 1 |
Abe, Y; Akiyama, O; Ito, M; Okura, H; Suga, Y; Tsutsumi, S; Yasumoto, Y | 1 |
Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
Adachi, H; Akamatsu, Y; Hashizume, H; Igarashi, M; Nishimura, Y | 1 |
Furugaki, K; Oyama, M; Yoshida, J | 1 |
Eriguchi, Y; Harada, Y; Kadowaki, M; Miyake, N; Nagasaki, Y; Sato, Y; Shimono, N; Uchida, Y | 1 |
Hwang, JH; Kim, JS; Lee, CS; Lee, JH; Moon, MK; Won, KS | 1 |
Miyake, N; Nagasaki, Y; Shimono, N; To, K | 1 |
Niki, Y | 1 |
Chung, KM; Hwang, JH; Kim, JS; Lee, CS; Lee, EJ; Lee, JH; Moon, MK; Won, KS; Yoon, YJ | 1 |
Sato, K | 1 |
Akamatsu, N; Hasegawa, H; Kawakami, K; Kimura, Y; Kosai, K; Matsuda, J; Matsuo, H; Morinaga, Y; Uno, N; Yamaryo, T; Yanagihara, K | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Agarwal, R; Agrawal, RP; Basu, I; Bhalla, H; Bs, M; Das, C; Deb, AK; Dube, A; Kurlekar, U; Padhye, D; Pawar, R; Shahavi, V; Singh, RM; Srivastava, A; Srivastava, P | 1 |
10 review(s) available for vancomycin and arbekacin
Article | Year |
---|---|
Synthetic access to thiolane-based therapeutics and biological activity studies.
Topics: Alkaloids; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Biological Products; Cell Survival; Fungi; Humans; Sesquiterpenes; Sulfhydryl Compounds | 2021 |
[Drug resistance of methicillin-resistant Staphylococcus aureus (MRSA) in Japan until 1993].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Japan; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Gram-positive cocci (include MRSA)].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1994 |
[Treatment of cancer and counter-measures for MRSA infections].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Cross Infection; Dibekacin; Disinfection; Female; Humans; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Patient Isolation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; Humans; Japan; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1998 |
[Methicillin resistant Staphylococcus aureus infection].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
[MRSA septicemia caused by an infected pacemaker lead: a case report with a review of Japanese literatures].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cardiopulmonary Bypass; Dibekacin; Drug Therapy, Combination; Female; Humans; Methicillin Resistance; Middle Aged; Minocycline; Pacemaker, Artificial; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2000 |
[MRSA].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Proteins; Bacterial Toxins; Dibekacin; Enterotoxins; Gentian Violet; Humans; Immunoglobulins, Intravenous; Methicillin Resistance; Repressor Proteins; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Teicoplanin; Vancomycin | 2001 |
[Appropriate usage of antibiotics by therapeutic drug monitoring].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Body Weight; Dibekacin; Drug Administration Schedule; Drug Monitoring; Extracellular Fluid; Humans; Infant, Newborn; Kidney; Patient Care Team; Renal Dialysis; Renal Insufficiency; Teicoplanin; Vancomycin | 2007 |
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
6 trial(s) available for vancomycin and arbekacin
Article | Year |
---|---|
[Laboratory and clinical studies on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1994 |
[Clinical efficacy of arbekacin on MRSA infections].
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bayes Theorem; Body Weight; Creatinine; Dibekacin; Female; Gestational Age; Glomerular Filtration Rate; Humans; Infant, Newborn; Male; Models, Biological; Population; Thienamycins; Vancomycin | 2004 |
Factors influencing neonatal therapeutic effect of anti-MRSA drugs.
Topics: Alanine Transaminase; Albumins; Aminoglycosides; Anti-Bacterial Agents; Blood Glucose; Blood Urea Nitrogen; C-Reactive Protein; Creatinine; Dibekacin; Drug Monitoring; Humans; Infant; Infant, Newborn; Logistic Models; Methicillin Resistance; Odds Ratio; Platelet Count; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin | 2005 |
Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus.
Topics: Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Dibekacin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Otitis Media, Suppurative; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2015 |
A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA Infection.
Topics: Anti-Bacterial Agents; Dibekacin; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2018 |
52 other study(ies) available for vancomycin and arbekacin
Article | Year |
---|---|
Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
Topics: Anti-Bacterial Agents; Cyclopropanes; Drug Resistance, Bacterial; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Stereoisomerism; Structure-Activity Relationship | 2003 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Drug Design; Drug Resistance, Multiple; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship | 2009 |
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |
[Septicemia caused by MRSA].
Topics: Aminoglycosides; Anti-Bacterial Agents; Catheterization; Dibekacin; Equipment Contamination; Humans; Methicillin Resistance; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[MRSA infections in neonates and premature infants].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[Chemotherapy of MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Combinations; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Vancomycin | 1992 |
[Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[A study on the resistance of methicillin resistant Staphylococcus aureus to antimicrobial agents].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Coagulase; Dibekacin; Drug Resistance, Microbial; Methicillin Resistance; Staphylococcus aureus; Vancomycin | 1994 |
Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Colony Count, Microbial; Dibekacin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1994 |
[Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dose-Response Relationship, Drug; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 1994 |
[Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Computer Simulation; Dibekacin; Gentamicins; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[A study on nephrotoxicity of arbekacin and vancomycin in rats].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Kidney; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution; Vancomycin | 1994 |
[Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Japan; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 1994 |
[MRSA infections in surgery].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Minocycline; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Clinical studies on methicillin-resistant Staphylococcus aureus (MRSA) infections].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Enterocolitis; Female; Humans; Immunocompromised Host; Male; Methicillin Resistance; Middle Aged; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Urinary Bladder Neoplasms; Vancomycin | 1993 |
[A study of methicillin-resistant Staphylococcus aureus (MRSA) infection in urological field].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Humans; Immunocompromised Host; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Urologic Diseases; Vancomycin | 1993 |
Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Dose-Response Relationship, Drug; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1997 |
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Humans; Infant; Male; Methicillin Resistance; Microbial Sensitivity Tests; Pulmonary Atresia; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin; Wounds and Injuries | 1997 |
[The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Vancomycin | 1997 |
[An epidemiological investigation for MRSA and PRSP in Kinki area. Kinki Infection Working Group].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Haemophilus influenzae; Humans; Japan; Methicillin Resistance; Penicillin Resistance; Pseudomonas aeruginosa; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1998 |
Effects of arbekacin and vancomycin on release of lactate dehydrogenase and fragmentation of DNA in LLC-PK1 kidney epithelial cells.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cisplatin; Dibekacin; DNA Damage; DNA Fragmentation; Kidney Tubules; L-Lactate Dehydrogenase; LLC-PK1 Cells; Necrosis; Swine; Vancomycin | 1999 |
[Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus aureus; Teicoplanin; Vancomycin | 1999 |
Methicillin-resistant Staphylococcus aureus (MRSA) isolated at Fukuoka University Hospital and hospitals and clinics in the Fukuoka city area.
Topics: Ambulatory Care Facilities; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cluster Analysis; Coagulase; Dibekacin; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Phylogeny; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Dibekacin; DNA, Bacterial; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sensitivity and Specificity; Staphylococcus aureus; Vancomycin | 2000 |
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Drug Therapy, Combination; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Methicillin Resistance; Postoperative Complications; Sepsis; Staphylococcal Infections; Sulbactam; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Dibekacin; DNA, Bacterial; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Streptomycin; Vancomycin | 2000 |
[Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cephalosporins; Dibekacin; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2001 |
[Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Blood; Culture Media; Depression, Chemical; Dibekacin; Dose-Response Relationship, Drug; Enterotoxins; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Teicoplanin; Vancomycin | 2001 |
Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Eye Infections, Bacterial; Female; Humans; Incidence; Keratitis; Male; Methicillin; Methicillin Resistance; Middle Aged; Ofloxacin; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2002 |
[Survey of susceptibility of methicillin-resistant Staphylococcus aureus to antimicrobial agents in Hokusetsu General Hospital].
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; Drug Resistance, Bacterial; Hospitals, General; Japan; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Teicoplanin; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |
Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Blood Coagulation; Colony Count, Microbial; Dibekacin; Drug Therapy, Combination; Endocarditis, Bacterial; Fibrin; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
[Sensitivity of MRSA isolated in our hospital to various antibacterial agents: changes over 5 years].
Topics: Aminoglycosides; Coagulase; Dibekacin; Drug Resistance, Bacterial; Enterotoxins; Humans; Imipenem; Methicillin Resistance; Netilmicin; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 2004 |
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Minocycline; Probability; Sampling Studies; Sensitivity and Specificity; Staphylococcus; Tigecycline; Vancomycin | 2004 |
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Teicoplanin; Vancomycin; Virginiamycin | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
[Appropriate use of anti-MRSA drugs (discussion)].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Dibekacin; Humans; Immunocompromised Host; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
[Analysis of factors in selecting anti-methicillin-resistant Staphylococcus aureus drugs by doctors].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Humans; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2008 |
[Appropriate use of anti-methicillin-resistant Staphylococcus aureus agents in a retrospective study].
Topics: Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2008 |
[Analysis of factors affecting long-term administration of anti-methicillin resistant Staphylococcus aureus (MRSA) drugs].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dibekacin; Humans; Immunosuppressive Agents; Methicillin Resistance; Multivariate Analysis; Serum Albumin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2009 |
[Case with large abdominal abscess associated with a ventriculoperitoneal shunt].
Topics: Abdominal Abscess; Anti-Bacterial Agents; Brain Abscess; Child; Dibekacin; Drainage; Female; Humans; Immunocompromised Host; Staphylococcal Infections; Vancomycin; Ventriculoperitoneal Shunt | 2009 |
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.
Topics: Actinomycetales; Anti-Bacterial Agents; Cell Membrane; Dibekacin; Enterococcus faecalis; Fluorescent Dyes; Membrane Potentials; Microbial Sensitivity Tests; Novobiocin; Peptides, Cyclic; Staphylococcus aureus; Vancomycin | 2010 |
Perioperative antimicrobials in chest surgery patients positive for methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Dibekacin; Drug Administration Schedule; Guideline Adherence; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Perioperative Care; Practice Guidelines as Topic; Pulmonary Surgical Procedures; Staphylococcal Infections; Surgical Wound Infection; Time Factors; Treatment Outcome; Vancomycin | 2010 |
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Cefazolin; Ciprofloxacin; Dibekacin; Drug Resistance, Bacterial; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Thienamycins; Vancomycin | 2011 |
The usefulness of arbekacin compared to vancomycin.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Dibekacin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA.
Topics: Adult; Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Endocarditis; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
External ocular infections due to methicillin-resistant Staphylococcus aureus and medical history.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Conjunctivitis; Cross-Sectional Studies; Dacryocystitis; Dibekacin; Eye Infections, Bacterial; Female; Humans; Infant; Keratitis, Herpetic; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2015 |
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cross Infection; Daptomycin; Dibekacin; Exotoxins; Humans; Japan; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Open Reading Frames; Recombinases; Secondary Care Centers; Skin; Soft Tissue Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |